Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis.
van den Elskamp IJ, Boden B, Dattola V, Knol DL, Filippi M, Kappos L, Fazekas F, Wagner K, Pohl C, Sandbrink R, Polman CH, Uitdehaag BM, Barkhof F.
van den Elskamp IJ, et al. Among authors: uitdehaag bm.
Neuroradiology. 2010 Oct;52(10):875-81. doi: 10.1007/s00234-009-0645-1. Epub 2010 Jan 5.
Neuroradiology. 2010.
PMID: 20049424
Free PMC article.
Clinical Trial.